CETAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Cetamide patents expire, and what generic alternatives are available?
Cetamide is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in CETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetamide
A generic version of CETAMIDE was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
Summary for CETAMIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Patent Applications: | 3,911 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CETAMIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CETAMIDE
US Patents and Regulatory Information for CETAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | CETAMIDE | sulfacetamide sodium | OINTMENT;OPHTHALMIC | 080021-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |